Research Project

Project Title:

OL Extension Study of LNP023 in C3G

Project Type:

Clinical Trial, Enrolment terminated

Disease group(s):

Immune glomerulopathies

Project Summary:

This is an open-label extension study to evaluate the long-term efficacy, safety and tolerability of LNP023 in subjects with C3 glomerulopathy.

Lead principal investigator(s):



Erica Daina, Bergamo

Project Period:

01/2020   -   12/2028

« Back to research page